Spero Therapeutics, Inc. (SPRO)
$1.12-2.61%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $65M
- Beta
- 1.50
- P/E (TTM)
- 8.00
- Short % float
- 1.71%
- Days to cover
- 1.0
- SI change
- -18.6%
- 1W
- -4.27%
- 1M
- -0.88%
- vs SPY 1W
- -3.29%
- vs SPY 1M
- -2.75%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SPRO?
- LOPJLB’s latest quantitative signal on Spero Therapeutics, Inc. (SPRO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SPRO in?
- Spero Therapeutics, Inc. (SPRO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Spero Therapeutics, Inc. (SPRO) do?
- Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-c…